Innovative Medicines Initiative Consultation on ATMPs

The Innovative Medicines Initiative (IMI) has issued a Consultation Paper on facilitating the translation of advanced therapies to patients in Europe. Against the background of growing research into Advanced Therapy Medicinal Products (ATMPs) IMI has developed a concept paper which aims to identify the potential of IMI as a platform for enhancing ATMP research and development.

Contributors who wish to submit comments on the concept paper are encouraged to consider in particular the following questions:

  • Have the key challenges that can be addressed through collaborative, public-private initiatives been properly identified?
  • Which of the proposed potential initiatives should be prioritised?
  • Are any areas missing?
  • What are the key European or national initiatives that IMI shall synergise with?

Deadline for submitting comments is 25 July 2016. Comments on the concept paper should be addressed by e-mail to .

Tagged with

Published on 17. June 2016 in News EU